Morphine: Patient Knowledge and Attitudes in the Central Anatolia Part of Turkey

Colak, Dilsen; Oğuz, Arzu; Yazılıtaş, Doğan; Imamoglu, Inanc Goksen; Altınbaş, Mustafa

doi:10.7314/apjcp.2014.15.12.4983

Cited by 10 publications

(19 citation statements)

References 18 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, the overuse of opioids for the treatment of migraine is related to medication overuse headache. The use of opioids eight days a month is a risk factor of medication overuse headache [8]. Taking into account that the patients were not off ered or prescribed opioid analgesics in the current study, we did not observe any association with chronifi cation of migraine and medication overuse headache.…”

Section: Discussioncontrasting

confidence: 49%

“…This suggests that migraine chronicity had no connection with opioid use. Some studies report that both patients and physicians tend to avoid such drugs in the treatment of pain due to opiophobia in patients with chronic pain [8,9,11]. Opiophobia, defi ned as the irrational fear and prejudice against using opioids, is found among doctors because of the serious side eff ect profi le of these drugs and the need for close follow-up, and among patients due to their fear of stigmatization and being addicted to the drug [9].…”

Section: Discussionmentioning

confidence: 99%

“…Although the benefi ts are not supported by any evidence-based study, the use of opioids in migraine patients in emergency departments is quite common in countries such as the United States and Canada [6,7]. There have been studies evaluating opiophobia, prejudice against the use of opioid analgesics by patients and physicians, and the use of opioids for the management of cancer pain in Turkey [8,9]. However, the frequency of opi-oid use in Turkish migraineurs has not been well documented.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Opioids and Migraine: Opioid Awareness and Frequency of Use among Turkish Migraineurs

Ertem

Basarir

Baran

et al. 2019

Bezopasnost' i risk farmakoterapii

View full text Add to dashboard Cite

Despite the inadequate evidence of effi cacy and safety of opioid use for the treatment of migraine, it has been reported that patients with moderate to severe migraine headaches are prescribed opioids. Migraineurs may experience serious health impacts from opioids such as headache-related disability, psychiatric and cardiovascular comorbidities. The reduction of the risk of opioid abuse and prevention of an opioid epidemic are important public health challenges. The aim of this study was to assess the awareness of opioid therapy for migraine and the frequency of use among Turkish patients with episodic and chronic migraine. Materials and methods: consecutive migraine patients were enrolled in this cross-sectional study. A semi-structured questionnaire was developed and used by the researchers to assess the patients’ awareness of an opiod treatment option and the frequency of use of opioids for migraine treatment. Results. One hundred two patients were enrolled, of which 72 had episodic migraine and 30 had chronic migraine. All subjects reported that they had not been offered or prescribed any kind of opioids by general practitioners and neurologists for their headache. Besides, only 7 % of patients declared that they had heard of opioid treatment for migraine but they had never consulted their doctors about its effects. Conclusions. Our fi ndings demonstrated that opioids were not preferred as an option for acute or preventive migraine treatment by Turkish migraineurs and their physicians. The reduction of opioid prescription will help to prevent the development of medication overuse and opiate-induced headaches and drug addiction.

show abstract

Section: Discussioncontrasting

confidence: 49%

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Opioids and Migraine: Opioid Awareness and Frequency of Use among Turkish Migraineurs

Ertem

Basarir

Baran

et al. 2019

Bezopasnost' i risk farmakoterapii

View full text Add to dashboard Cite

show abstract

“…The results from the majority of studies with cancer patients reported that the mean scores on patient's knowledge and attitudes towards CPM were low, indicating poor understanding or negative attitudes towards CPM [19,20,57,77]. For example, a recent study conducted in China by Lou and Shang [57] reported through the Barriers Questionnaire-Taiwan (BQT; ranged from 0 to 5) that patients had negative attitudes towards CPM in six areas (scores ≥ 2.…”

Section: Overall Results Of Included Studiesmentioning

confidence: 99%

Managing Pain in People with Cancer—a Systematic Review of the Attitudes and Knowledge of Professionals, Patients, Caregivers and Public

et al. 2019

View full text Add to dashboard Cite

Cancer pain is a common symptom experienced by patients, caused either by the disease or its treatment. Morphine remains the most effective and recommended treatment for cancer pain. However, cancer patients still do not receive appropriate management for their pain, and under-treatment is common. Lack of knowledge and negative attitudes towards cancer pain and analgesia among professionals, patients and family caregivers are reported as one of the most common barriers to effective cancer pain management (CPM). To systematically review research on the nature and impact of attitudes and knowledge towards CPM, a systematic literature search of 6 databases (the Cochrane library, MEDLINE, PsycINFO, CINAHL, Web of Science and EMBASE) was undertaken in July 2018. Additionally, hand-searching of Google, Google Scholar and reference lists was conducted. The inclusion criteria were adult (18-65 years of age), studies which included attitudes and knowledge towards CPM, studies written in English, published literature only and cross-sectional design. Included studies were critically appraised by two researchers independently using the Joanna Briggs Institute Analytical Cross Sectional Studies Assessment (JBI-ACSSA). A total of 36 studies met the inclusion criteria. The main finding was that among professionals, patients, caregivers and the public there were similar attitudinal barriers to effective CPM. The most commonly cited barriers were fear of drug addiction, tolerance of medication and side effects of opioids. We also found differences between professional groups (physicians versus nurses) and between different countries based on their potential exposure to palliative care training and services. There are still barriers to effective CPM, which might result in unrelieved cancer pain. Therefore, more educational programmes and training for professionals on CPM are needed. Furthermore, patients, caregivers, and the public need more general awareness and adequate level of knowledge about CPM.

show abstract

“…However complete pain relief is rarely achieved, and cancer-related pain remains undertreated throughout the world (Azevedo Sao Leao Ferreira et al, 2006;Brant 2010). The failure to manage pain properly is due to suboptimal usage of opioids because of several factors including limited resources, legal restrictions, failure to follow existing guidelines and patient related factors (Davis and Walsh, 2004) as well as the lack of physician education (Budkaew and Chumworathayi, 2013) Beliefs about pain and opioids demonstreated a significant relationship with patients' opioid adherence (Liang et al, 2013;Colak et al, 2014).…”

Section: Introductionmentioning

confidence: 99%

Determinants of Opioid Efficiency in Cancer Pain: a Comprehensive Multivariate Analysis from a Tertiary Cancer Centre

Göksu¹,

Bozcuk²,

Uysal³

et al. 2014

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Background: Pain is one of the most terrifying symptoms for cancer patients. Although most patients with cancer pain need opioids, complete relief of pain is hard to achieve. This study investigated the factors influencing persistent pain-free survival (PPFS) and opioid efficiency. Materials and Methods: A prospective study was conducted on 100 patients with cancer pain, hospitalized at the medical oncology clinic of Akdeniz University. Patient records were collected including patient demographics, the disease, treatment characteristics, and details of opioid usage. Pain intensity was measured using a patient self-reported visual analogue scale (VAS). The area under the curve (AUC) reflecting the pain load was calculated from daily VAS tables. PPFS, the primary measure of opioid efficacy, was described as the duration for which a patient reported a greater than or equal to two-point decline in their VAS for pain. Predictors of opioid efficacy were analysed using a multivariate analysis.

show abstract

Morphine: Patient Knowledge and Attitudes in the Central Anatolia Part of Turkey

Cited by 10 publications

References 18 publications

Opioids and Migraine: Opioid Awareness and Frequency of Use among Turkish Migraineurs

Opioids and Migraine: Opioid Awareness and Frequency of Use among Turkish Migraineurs

Managing Pain in People with Cancer—a Systematic Review of the Attitudes and Knowledge of Professionals, Patients, Caregivers and Public

Determinants of Opioid Efficiency in Cancer Pain: a Comprehensive Multivariate Analysis from a Tertiary Cancer Centre

Contact Info

Product

Resources

About